Type
. Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control. Future microbiology [Internet]. 2018;. Available from: https://www.futuremedicine.com/doi/pdf/10.2217/fmb-2018-0186
Type
. Erythema Nodosum Leprosum Triggered by Antecedent Influenza Vaccine and Respiratory Tract Infection: A Case Report. Journal of cutaneous medicine and surgery. 2018;.
Type
. Armadillos Bring Risk of Leprosy. JAMA. 2018;320(11):1097.
Type
. [Methodology for approach of the social stigma of the diseases in the medicine course: experience report]. Rev Inter Educ Saúde [Internet]. 2018;2(1):120-123. Available from: https://www5.bahiana.edu.br/index.php/educacao/article/view/1829
Type
. The Overview of Anti-PGL-1 and Anti-IDALLE L-ESAT 6 IgG Antibody Titers in Household Contact of Leprosy. International Conference on Sustainable Health Promotion [Internet]. 2018;:1-4. Available from: http://proceedings.uinsby.ac.id/index.php/ICOSHPRO/article/view/3/1
Type
. LEPRASIM, an Agent-Based Model to simulate leprosy in Indonesia. 12th International Symposium on Geospatial Health 2018. 2018;(12).
Type
. Mid borderline leprosy in type Bα Blaschko linear pattern: a rare phenomenon. International journal of dermatology. 2018;.
Type
. Leprosy among children in Senegal. Journal of disease and global health. 2017;10(3):89-92.
Type
. Leprosy mimicking a diabetic dermopathy. Pahang Research Day 2018 [Internet]. 2018;. Available from: https://tinyurl.com/y8er9cnu
Type
. Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction. Frontiers in medicine [Internet]. 2018;5:263. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2018.00263/full